Apixaban in bridge to transplant and destination LVAD ‐ rationale and study design: the ApixiVAD trial
Abstract Aims Use of novel anticoagulation in mechanical circulatory support is controversial. We report the rationale and design of the ApixiVad pilot trial, a pilot study testing the safety of apixaban as an anticoagulant in patients bridged to transplant (BTT) or for destination (DT) with Heartma...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2024-08-01
|
| Col·lecció: | ESC Heart Failure |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ehf2.14782 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|